Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission

Saved in:
Bibliographic Details
Published in:Open Forum Infectious Diseases
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871928243805749248
collection WordPress RSS
FRELIP Feed Integration
container_title Open Forum Infectious Diseases
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:107531
institution FRELIP
journal_source_facet Open Forum Infectious Diseases
last_indexed 2026-07-28T03:38:08.250Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_alt Cabotegravir/rilpivirina inyectable de acción prolongada como régimen de TAR de segunda línea para mujeres embarazadas y lactantes en Kenia: modelado del impacto potencial en la transmisión vertical
Cabotégravir/rilpivirine injectable à action prolongée comme régime ART de deuxième ligne pour les femmes enceintes et allaitantes au Kenya : modélisation de l'impact potentiel sur la transmission verticale
Cabotegravir/rilpivirina injetável de longa duração como regime de TARV de segunda linha para mulheres grávidas e lactantes no Quênia: modelagem do impacto potencial na transmissão vertical
title_auth Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_es_txt Cabotegravir/rilpivirina inyectable de acción prolongada como régimen de TAR de segunda línea para mujeres embarazadas y lactantes en Kenia: modelado del impacto potencial en la transmisión vertical
title_fr_txt Cabotégravir/rilpivirine injectable à action prolongée comme régime ART de deuxième ligne pour les femmes enceintes et allaitantes au Kenya : modélisation de l'impact potentiel sur la transmission verticale
title_full Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_fullStr Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_full_unstemmed Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_pt_txt Cabotegravir/rilpivirina injetável de longa duração como regime de TARV de segunda linha para mulheres grávidas e lactantes no Quênia: modelagem do impacto potencial na transmissão vertical
title_short Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission
title_sort long-acting injectable cabotegravir/rilpivirine as a second-line art regimen for pregnant and breastfeeding women in kenya: modeling the potential impact on vertical transmission
topic Allergology and Immunology
General
Allergology and Immunology
url https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag463/8741589?rss=1